Related Experiment Videos
Combining scales to assess suicide risk
Hilario Blasco-Fontecilla1, David Delgado-Gomez, Diego Ruiz-Hernandez
1Department of Psychiatry, Puerta de Hierro Hospital, CIBERSAM, Calle Manuel de Falla 1, 28222 Majadahonda, Spain. hmblasco@yahoo.es
Journal of Psychiatric Research
|July 17, 2012
Summary
Researchers identified 27 key items for a new suicide risk assessment scale. This tool aims for accurate, clinician-friendly screening of suicidal behavior.
Area of Science:
- Psychiatry
- Psychometrics
- Clinical Psychology
Background:
- Accurate suicide risk assessment is crucial for clinical practice.
- Existing scales are often lengthy and difficult to implement.
- There is a need for a concise and effective suicide risk screening tool.
Purpose of the Study:
- To identify the most discriminative items from established scales for assessing suicidal behavior.
- To develop a shorter, more clinically applicable instrument for suicide risk evaluation.
Main Methods:
- Utilized the Lars-en algorithm to analyze responses from 687 subjects (suicide attempters, non-suicidal psychiatric inpatients, healthy controls).
- Data from Barrat Impulsiveness Scale, International Personality Disorder Evaluation Screening Questionnaire, Brown-Goodwin Lifetime History of Aggression, and Holmes & Rahe Social Readjustment Rating Scale were analyzed.
- Selected 27 items from a pool of 154 to identify discriminative features of suicidal behavior.
Main Results:
- Achieved an average accuracy of 86.4% in classifying suicide attempters.
- Demonstrated a specificity of 89.6% and a sensitivity of 80.8% using the selected 27 items.
- The identified items effectively discriminate between suicide attempters and control groups.
Conclusions:
- The 27 selected items represent a promising preliminary step towards a new suicide risk assessment scale.
- This concise set of items could facilitate rapid and accurate suicide risk screening in time-constrained clinical settings.
- Further development of this scale is recommended for widespread clinical adoption.